Showing results (231-240 of 464) with videos related to
Sort By:
Pageof 47
Cancer Biology & Therapy|December 25, 2008
Role of PI3K/Akt signaling in TRAIL- and radiation-induced gastrointestinal apoptosisJohn P Plastaras, Jay F Dorsey, Kristina Carroll, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Suppression of cancer cell growth by adenovirus expressing p21(WAF1/CIP1) deficient in PCNA interactionN S Prabhu, M V Blagosklonny, Y X Zeng, et al.Cancer Biology & Therapy|July 16, 2011
Spectral imaging-based methods for quantifying autophagy and apoptosisNathan G Dolloff, Xiahong Ma, David T Dicker, et al.Cancers|February 13, 2025
Heterogeneity in CancerWilliam J MacDonald, Connor Purcell, Maximilian Pinho-Schwermann, et al.Cancer Biology & Therapy|September 9, 2017
Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancerAvital Lev, Safoora Deihimi, Elena Shagisultanova, et al.International Journal of Oncology|July 13, 1999
The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicityN S Prabhu, K Somasundaram, H Tian, et al.Expert Opinion on Therapeutic Targets|May 26, 2015
Targeting TRAIL in the treatment of cancer: new developmentsBora Lim, Joshua E Allen, Varun V Prabhu, et al.Cancer Biology & Therapy|October 13, 2007
Multimodality optical imaging and 18F-FDG uptake in wild-type p53-containing and p53-null human colon tumor xenograftsShulin Wang, Akiva Mintz, Kenjiro Mochizuki, et al.Cancer Biology & Therapy|October 24, 2007
Childhood ALL and second neoplasmsTapan N Maniar, Inbal Braunstein, Stephen Keefe, et al.Science Translational Medicine|June 10, 2011
Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulationNathan G Dolloff, Patrick A Mayes, Lori S Hart, et al.Pageof 47